Prodromes of first-episode psychosis: How can we challenge nonspecificity?

Comprehensive Psychiatry

Volumn 42, Issue 5, 2001, Pages 382-392

  Simon, Andor E ^a   Ferrero, François P ^a   Merlo, Marco C G ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; FLUPENTIXOL; NEUROLEPTIC AGENT; RISPERIDONE;

ARTICLE; COGNITIVE DEFECT; DELUSION; EARLY DIAGNOSIS; HUMAN; PHENOMENOLOGY; PRIMARY PREVENTION; PSYCHOSIS; SCHIZOPHRENIA; SECONDARY PREVENTION; SOCIAL PSYCHOLOGY; SYMPTOM;

EID: 0034836508     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1053/comp.2001.26272     Document Type: Article

References (71)

1. The history of mental symptoms
2. Early detection and intervention with schizophrenia: Rationale
3. EPPIC: An evolving system of early detection and optimal management
4. Sharpening the focus: Early intervention in the real world
5. When and how does schizophrenia produce social deficits?
6. From predisposition to psychosis: Progression of symptoms in schizophrenia
7. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia
8. A neuropsychological study of early onset schizophrenia
9. Early intervention in psychosis
10. Duration of untreated psychosis in first-episode schizophrenia: Marker or determinant of course?
11. Who cares? Pathways to psychiatric care in early psychosis
12. Promoting access to care in early psychosis
13. Children at risk for schizophrenia: Converging lines of evidence
14. The prodromal phase of first episode psychosis: Past and current conceptualisations
15. Hillside study of risk and early detection in schizophrenia
16. Prodromal symptoms in schizophrenia
17. The onset of schizophrenia
18. The prevalence of prodromal features of schizophrenia in adolescence: A preliminary survey
19. The diagnosis of schizophrenia: A review of onset and duration issues
20. Diagnosis of schizophrenia: A review
21. Hallucinations and delusions as points on continua function
22. Schizotaxia, schizotypy, schizophrenia
23. Schizotaxia revisited
24. 'Schizotaxia': Clinical implications and new directions for research
25. Toward reformulating the diagnosis of schizophrenia
26. Can we improve the diagnostic efficiency and predictive power of prodromal symptoms for schizophrenia?
27. Scales for rating psychotic and psychotic-like experiences as continua
28. IRAOS: An instrument for the assessment of onset and early course of schizophrenia
29. Deviant olfactory experiences as indicators of risk for psychosis
30. Psychopatholoy of basic stages of schizophrenia in view of formal thought disturbances
31. Beginning schizophrenia observed by significant others
32. Substance abuse and the onset of schizophrenia
33. Early diagnosis of schizophrenia
34. Prodromes and primary prevention of schizophrenic psychoses
35. Early self-experienced neuropsychological deficits and subsequent schizophrenic diseases: An 8-year average follow-up prospective study
36. Putatively psychosis-prone subjects 10 years later
37. Attention, memory, and motor skills as childhood predicotrs of schizophrenia-related psychosis: The New York high-risk project
38. Cognitive and behavioral precursors of schizophrenia
39. Treatment of nonpsychotic relatives of patients with schizophrenia: Four case studies
40. Der Verlust der natürlichen selbstverständlichkeit
41. Self-experience in the prodromal phase of schizophrenia: A pilot study of first-admissions
42. The initial prodorme in schizophrenia
43. Symptoms in the mind
44. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort
45. A prospective cohort study of childhood behavioral deviance and language abnormalities as predictors of adult schizophrenia
46. Effects of substance misuse in early psychosis
47. Impact of duration of symptoms prior to first hospitalization on acute outcome in 998 schizophrenic patients
48. Premorbid and onset features of first episode schizophrenia
49. Twenty years' follow up of first psychiatric presentation for schizophrenia: What could have been prevented?
50. Duration of untreated psychosis and outcome in first episode schizophrenia
51. The northwick park first episodes of schizophrenia. III. Short-term outcome in trial entrants and trial eligible patients
52. Should schizophrenia be treated as a neurocognitive disorder?
53. Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: A re-analysis of the Camarillo State Hospital data
54. Health and economic evaluation in schizophrenia: Implications for health policies
55. Early intervention for first episodes of schizophrenia. A preliminary exploration
56. First-episode schizophrenia: Do grandiosity, disorganization, and acute initial development reduce duration of untreated psychosis? An exploratory naturalistic case study
57. Pactice guideline for the treatment of patients with schizophrenia
58. Pharmacologic treatment of first-episode schizophrenia: Early intervention is key to outcome
59. The development of preventive interventions for early psychosis: Early findings and directions for the future
60. The Hillside RAPP Clinic: A research/early intervention center for the schizophrenia prodrome